Hüseyin Firat - Concepedia

Author

Hüseyin Firat

Also Known As

Firat, H., Firat1, Hüseyin, H Firat, H. FIRAT, H. Firat, Huseyin C. Firat, Huseyin Firat, Hüseyin Firat, Hüseyin FIRAT, Hüseyin Firat

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Institut Pasteur Inserm Centre National de la Recherche Scientifique Firalis (France)Sorbonne Université

About

Hüseyin Firat is an author at Institut Pasteur specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	1.4K
2	Cell Biology	13	14	1.2K
3	Health Sciences	3	3	118
4	Allergy	3	3	82
5	Biomedical Engineering	2	2	89

Hüseyin Firat

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Cytotoxic T cell immunity against telomerase reverse transcriptase in humans Boris Minev, Jason Hipp, Hüseyin Firat, Proceedings of the National Academy of Sciences Htrt PeptidesCancer ImmunosurveillanceTelomerase PeptidesMedicineTelomerase Activity	2000	255
Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. Patricia Yotnda, Hüseyin Firat, Francisco Garcia‐Pons, Journal of Clinical Investigation Hematological MalignancySystems BiologyMixed-phenotype Acute LeukemiaMalignant Blood DisorderHla Immunogenetics	1998	238
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results Dan Atar, Håkan Arheden, Alain Berdeaux, European Heart Journal	2014	183
H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies Hüseyin Firat, Francisco Garcia‐Pons, Sophie Tourdot, European Journal of Immunology HistocompatibilityH-2 ClassHla ImmunogeneticsImmunologyHhd Mice	1999	176
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy David‐Alexandre Gross, Stéphanie Graff‐Dubois, Paule Opolon, Journal of Clinical Investigation ImmunologyImmunotherapyTumor BiologyTumor ImmunologyVaccine Target	2004	122
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy David‐Alexandre Gross, Stéphanie Graff‐Dubois, Paule Opolon, Journal of Clinical Investigation ImmunologyImmunotherapyTumor BiologyTumor ImmunologyVaccine Target	2004	109
Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells Javier Hernández, Francisco Garcia‐Pons, Yu Chun Lone, Proceedings of the National Academy of Sciences	2002	90
Human Transporters Associated with Antigen Processing (Taps) Select Epitope Precursor Peptides for Processing in the Endoplasmic Reticulum and Presentation to T Cells Grégoire Lauvau, Kazuhiro Kakimi, Gabriele Niedermann, The Journal of Experimental Medicine	1999	90
An HLA-A2 Polyepitope Vaccine for Melanoma Immunotherapy Luis Mateo, Joy Gardner, Qiyuan Chen, The Journal of Immunology VaccinationTumor ImmunologyCancer ImmunosurveillanceImmunologyPolytope Approach	1999	83
Ultrastructural and Morphological Analyses of the In Vitro and In Vivo Hemostatic Effects of Ankaferd Blood Stopper Berat Z. Haznedaroğlu, İbrahim C. Haznedaroğlu, Sharon L. Walker, Clinical and Applied Thrombosis/Hemostasis Blood CellSurgeryBiomedical EngineeringThrombosisAnkaferd Blood Stopper	2009	74

Page 1